These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo. López I; Rodríguez-Ortiz ME; Almadén Y; Guerrero F; de Oca AM; Pineda C; Shalhoub V; Rodríguez M; Aguilera-Tejero E Kidney Int; 2011 Sep; 80(5):475-82. PubMed ID: 21525854 [TBL] [Abstract][Full Text] [Related]
4. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Lavi-Moshayoff V; Wasserman G; Meir T; Silver J; Naveh-Many T Am J Physiol Renal Physiol; 2010 Oct; 299(4):F882-9. PubMed ID: 20685823 [TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription. Meir T; Durlacher K; Pan Z; Amir G; Richards WG; Silver J; Naveh-Many T Kidney Int; 2014 Dec; 86(6):1106-15. PubMed ID: 24940803 [TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTH. Saji F; Shigematsu T; Sakaguchi T; Ohya M; Orita H; Maeda Y; Ooura M; Mima T; Negi S Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1212-7. PubMed ID: 20739393 [TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men. Marsell R; Grundberg E; Krajisnik T; Mallmin H; Karlsson M; Mellström D; Orwoll E; Ohlsson C; Jonsson KB; Ljunggren O; Larsson TE Eur J Endocrinol; 2008 Jan; 158(1):125-9. PubMed ID: 18166826 [TBL] [Abstract][Full Text] [Related]
10. The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease. Taal MW; Thurston V; McIntyre NJ; Fluck RJ; McIntyre CW Kidney Int; 2014 Aug; 86(2):407-13. PubMed ID: 24429404 [TBL] [Abstract][Full Text] [Related]
11. Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats. Nagano N; Miyata S; Abe M; Kobayashi N; Wakita S; Yamashita T; Wada M Kidney Int; 2006 Feb; 69(3):531-7. PubMed ID: 16395276 [TBL] [Abstract][Full Text] [Related]
12. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis. Koizumi M; Komaba H; Fukagawa M Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554 [TBL] [Abstract][Full Text] [Related]
13. FGF23 regulation of phosphorus homeostasis is dependent on PTH. Clarke BL Endocrinology; 2011 Nov; 152(11):4016-8. PubMed ID: 22021200 [No Abstract] [Full Text] [Related]
14. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation. Sánchez Fructuoso AI; Maestro ML; Calvo N; De La Orden V; Pérez Flores I; Vidaurreta M; Valero R; Fernández-Pérez C; Barrientos A Transplant Proc; 2012 Nov; 44(9):2551-4. PubMed ID: 23146451 [TBL] [Abstract][Full Text] [Related]
15. Klotho, FGF23, and FGF receptors in chronic kidney disease: a yin-yang situation? Drüeke TB Kidney Int; 2010 Dec; 78(11):1057-60. PubMed ID: 21076444 [TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health Study. Brandenburg VM; Kleber ME; Vervloet MG; Tomaschitz A; Pilz S; Stojakovic T; Delgado G; Grammer TB; Marx N; März W; Scharnagl H Atherosclerosis; 2014 Nov; 237(1):53-9. PubMed ID: 25200615 [TBL] [Abstract][Full Text] [Related]
17. Determinants of fibroblast growth factor-23 and parathyroid hormone variability in dialysis patients. Jia T; Qureshi AR; Brandenburg V; Ketteler M; Barany P; Heimburger O; Uhlin F; Magnusson P; Fernström A; Lindholm B; Stenvinkel P; Larsson TE Am J Nephrol; 2013; 37(5):462-71. PubMed ID: 23635517 [TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 23, but not parathyroid hormone, is associated with urinary phosphate regulation in patients on peritoneal dialysis. Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Hasegawa S; Tanaka S; Eriguchi M; Nakano T; Masutani K; Ooboshi H; Kitazono T Ther Apher Dial; 2015 Feb; 19(1):73-80. PubMed ID: 25195562 [TBL] [Abstract][Full Text] [Related]
19. Cinacalcet treatment decreases plasma fibroblast growth factor 23 concentration in haemodialysed patients with chronic kidney disease and secondary hyperparathyroidism. Kuczera P; Adamczak M; Wiecek A Clin Endocrinol (Oxf); 2014 Apr; 80(4):607-12. PubMed ID: 24111496 [TBL] [Abstract][Full Text] [Related]
20. The rise of FGF23: should insights from population-based studies inform future clinical trials? Wetmore JB Kidney Int; 2016 Sep; 90(3):477-9. PubMed ID: 27521109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]